What Is Next in This “Age” of Heme-Driven Pathology and Protection by Hemopexin? An Update and Links with Iron
This review provides a synopsis of the published literature over the past two years on the heme-binding protein hemopexin (HPX), with some background information on the biochemistry of the HPX system. One focus is on the mechanisms of heme-driven pathology in the context of heme and iron homeostasis...
Main Authors: | Luis Montecinos, Jeffrey D. Eskew, Ann Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/12/4/144 |
Similar Items
-
Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders.
by: Ann eSmith, et al.
Published: (2015-06-01) -
Human Plasma and Recombinant Hemopexins: Heme Binding Revisited
by: Elena Karnaukhova, et al.
Published: (2021-01-01) -
Hemopexin as an Inhibitor of Hemolysis-Induced Complement Activation
by: Victoria Poillerat, et al.
Published: (2020-07-01) -
TLR4 Signaling by Heme and the Role of Heme-Binding Blood Proteins
by: Sabina Janciauskiene, et al.
Published: (2020-08-01) -
Labile Heme and Heme Oxygenase‐1 Maintain Tumor‐Permissive Niche for Endometriosis‐Associated Ovarian Cancer
by: Canesin, G., et al.
Published: (2022)